Takuro Hisanaga

Early Predictors of Objective Response in Patients with Hepatocellular Carcinoma Undergoing Lenvatinib Treatment

Issei Saeki, Takahiro Yamasaki, Satoyoshi Yamashita et al. · Cancers · 2020 · 43 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Bone-marrow-derived cells cultured in serum-free medium reduce liver fibrosis and improve liver function in carbon-tetrachloride-treated cirrhotic mice

Takuya Iwamoto, Shuji Terai, Takuro Hisanaga et al. · Cell and Tissue Research · 2012 · 33 citations

Medicine, Cell Biology, Pathology +17

No Muscle Depletion with High Visceral Fat as a Novel Beneficial Biomarker of Sorafenib for Hepatocellular Carcinoma

Issei Saeki, Takahiro Yamasaki, Masaki Maeda et al. · Liver Cancer · 2018 · 31 citations · Full text

Medicine, Oncology, Cancer Pharmacology +16

Predictors of the Effect of Tolvaptan on the Prognosis of Cirrhosis

Takuya Iwamoto, Masaki Maeda, Takuro Hisanaga et al. · Internal Medicine · 2016 · 19 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Evaluation of the “assessment for continuous treatment with hepatic arterial infusion chemotherapy” scoring system in patients with advanced hepatocellular carcinoma

Issei Saeki, Takahiro Yamasaki, Masaki Maeda et al. · Hepatology Research · 2017 · 16 citations · Full text

Medicine, Oncology, Cancer Control +14